Published online before print January 3, 2002, doi: 10.1161/hh0302.104532
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 22, 2001
Revised on December 19, 2001
Accepted on December 19, 2001
Mutations of the Light Meromyosin Domain of the ß-Myosin Heavy Chain Rod in Hypertrophic Cardiomyopathy
From the Departments of Cardiovascular Medicine (E.B., C.R., M.J.O., H.W.) and Paediatric Cardiology (I.O.S.), University of Oxford and John Radcliffe Hospital, Oxford, UK; the US/MRC Centre for Molecular and Cellular Biology (J.C.M.S., V.A.C.) and the Department of Internal Medicine and Tygerberg Hospital (P.B.), University of Stellenbosch, Tygerberg, South Africa.
* To whom correspondence should be addressed. E-mail: eblair{at}molbiol.ox.ac.uk.
Familial hypertrophic cardiomyopathy (HCM) is caused by mutations in 9 sarcomeric protein genes. The most commonly affected is ß-myosin heavy chain (MYH7), where missense mutations cluster in the head and neck regions and directly affect motor function. Comparable mutations have not been described in the light meromyosin (LMM) region of the myosin rod, nor would these be expected to directly affect motor function. We studied 82 probands with HCM in whom no mutations had been found in MYH7 exons encoding the head and neck regions of myosin nor in the other frequently implicated disease genes. Primers were designed to amplify exons 24 to 40 of MYH7. These amplimers were subjected to temperature modulated heteroduplex analysis by DHPLC. An Ala1379Thr missense mutation in exon 30 segregated with disease in three families and was not present in 200 normal chromosomes. The mutation occurred on two haplotypes, indicating that it was not a polymorphism linked with another disease-causing mutation. The position of this residue within the LMM region of myosin suggests that it may be important for thick filament assembly or for accessory protein binding. A further missense mutation in exon 37, Ser1776Gly, segregated with disease in a single family and was absent from 400 population-matched control chromosomes. Because the Ser1776 residue occupies a core position in the myosin rod at which the substitution of glycine is extremely energetically unfavorable, it is likely to disrupt the coiled-coil structure. We conclude that mutation of the LMM can cause HCM and that such mutations may act through novel mechanisms of disease pathogenesis involving myosin filament assembly or interaction with thick filament binding proteins.
Key words: hypertrophic cardiomyopathy • myosin
This article has been cited by other articles:
 |
|
 |
|
  S. Klaassen, S. Probst, E. Oechslin, B. Gerull, G. Krings, P. Schuler, M. Greutmann, D. Hurlimann, M. Yegitbasi, L. Pons, et al. Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction Circulation, June 3, 2008; 117(22): 2893 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Darin, H. Tajsharghi, I. Ostman-Smith, T. Gilljam, and A. Oldfors NEW SKELETAL MYOPATHY AND CARDIOMYOPATHY ASSOCIATED WITH A MISSENSE MUTATION IN MYH7 Neurology, June 5, 2007; 68(23): 2041 - 2042. [Full Text] [PDF]
|
|
|
|
|
|
E. Carniel, M. R.G. Taylor, G. Sinagra, A. Di Lenarda, L. Ku, P. R. Fain, M. M. Boucek, J. Cavanaugh, S. Miocic, D. Slavov, et al. {alpha}-Myosin Heavy Chain: A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy Circulation, July 5, 2005; 112(1): 54 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Villard, L. Duboscq-Bidot, P. Charron, A. Benaiche, V. Conraads, N. Sylvius, and M. Komajda Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene Eur. Heart J., April 2, 2005; 26(8): 794 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oldfors, H. Tajsharghi, L. E. Thornell, and B. F. Meyer Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy Neurology, February 8, 2005; 64(3): 580 - 581. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Franke, F. Dong, W. L. Rickoll, M. J. Kelley, and D. P. Kiehart Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly Blood, January 1, 2005; 105(1): 161 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron, J.G. Seidman, and C. E. Seidman Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2125 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Karkkainen, T. Helio, P. Jaaskelainen, R. Miettinen, P. Tuomainen, K. Ylitalo, M. Kaartinen, E. Reissell, L. Toivonen, M. S. Nieminen, et al. Two novel mutations in the {beta}-myosin heavy chain gene associated with dilated cardiomyopathy Eur J Heart Fail, December 1, 2004; 6(7): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Van Driest, M. A. Jaeger, S. R. Ommen, M. L. Will, B. J. Gersh, A. J. Tajik, and M. J. Ackerman Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., August 4, 2004; 44(3): 602 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bohlega, S. N. Abu-Amero, S. M. Wakil, P. Carroll, R. Al-Amr, B. Lach, Y. Al-Sayed, E. J. Cupler, and B. F. Meyer Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy Neurology, May 11, 2004; 62(9): 1518 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Garcia-Castro, J. R. Reguero, A. Batalla, B. Diaz-Molina, P. Gonzalez, V. Alvarez, A. Cortina, G. I. Cubero, and E. Coto Hypertrophic Cardiomyopathy: Low Frequency of Mutations in the {beta}-Myosin Heavy Chain (MYH7) and Cardiac Troponin T (TNNT2) Genes among Spanish Patients Clin. Chem., August 1, 2003; 49(8): 1279 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Marian and R. Roberts To Screen or Not Is Not the Question-- It Is When and How to Screen Circulation, May 6, 2003; 107(17): 2171 - 2174. [Full Text] [PDF]
|
|
|
|
|
|
P. Richard, P. Charron, L. Carrier, C. Ledeuil, T. Cheav, C. Pichereau, A. Benaiche, R. Isnard, O. Dubourg, M. Burban, et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy Circulation, May 6, 2003; 107(17): 2227 - 2232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watkins Genetic Clues to Disease Pathways in Hypertrophic and Dilated Cardiomyopathies Circulation, March 18, 2003; 107(10): 1344 - 1346. [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. McNally {beta}-Myosin Heavy Chain Gene Mutations in Familial Hypertrophic Cardiomyopathy: The Usual Suspect? Circ. Res., February 22, 2002; 90(3): 246 - 247. [Full Text] [PDF]
|
|
|
|
 |
|
 H. MORITA, S.R. DEPALMA, M. ARAD, B. MCDONOUGH, S. BARR, C. DUFFY, B.J. MARON, C.E. SEIDMAN, and J.G. SEIDMAN Molecular Epidemiology of Hypertrophic Cardiomyopathy Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 383 - 388. [Abstract] [PDF]
|
|